British journal of haematologyAdultFemaleHumansPregnancyADAMTS13 Protein
Facing the bleeding risk of caplacizumab in postpartum immune thrombotic thrombocytopenic purpura in constrained resource settings.
José Rojas-Suarez, David Correa-Maldonado, Diego Cabarcas-Castilla, Arnold Castro-Giraldo, Gustavo Ahumada-Pla
Published: 202510.1111/bjh.20249
Abstract
A visual overview of postpartum immune-mediated TTP (iTTP) treated with caplacizumab in a constrained resource setting. Emphasises timely diagnosis, multidisciplinary management and adapted therapy despite restricted access to ADAMTS13/von Willebrand…
Preview only. Read the full abstract at the source